Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44

Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44

US Patent 11213571 · Granted Jan 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies to L-type voltage gated channels and related methods2024
Methods for diagnosing and treating Alzheimer's disease2024
Antibodies to L-type voltage gated channels and related methods2022
Methods for diagnosing and treating Alzheimer's disease2020
Method of enhancing an immune response2011
Pox viridae treatment2011
Method of enhancing an immune response2008
Use of p97 and iron binding proteins as diagnostic and therapeutic agents2002
Method of enhancing expression of MHC class I molecules bearing endogenous pepti2002
Use of p97 and iron binding proteins as diagnostic and therapeutic agents1999
Method of identifying MHC-class I restricted antigens endogenously processed by 1998